Interferon alpha monotherapy for chronic hepatitis C viral infection in thalassemics and hemodialysis patients

Journal of Chemotherapy

Volumn 17, Issue 6, 2005, Pages 651-655

  Artan, Reha ^a,b   Akcam, M ^a   Yilmaz, A ^a   Kocacik, D ^a  

^a AKDENIZ UNIVERSITY FACULTY OF MEDICINE   (Turkey)

^b AKDENIZ UNIVERSITY   (Turkey)

Author keywords

Chronic hepatitis; HCV; Hemodialysis; Interferon; Thalassemia

Indexed keywords

RECOMBINANT ALPHA2A INTERFERON; VIRUS RNA;

ADOLESCENT; ADULT; ANOREXIA; ARTHRALGIA; ARTICLE; BLOOD TRANSFUSION; CHILD; CLINICAL ARTICLE; DRUG EFFICACY; DRUG RESPONSE; FATIGUE; FEMALE; FEVER; HAIR LOSS; HEADACHE; HEMODIALYSIS; HEPATITIS C; HISTOPATHOLOGY; HUMAN; INSOMNIA; IRRITABILITY; LEUKOPENIA; LIVER HISTOLOGY; MALE; MYALGIA; NAUSEA; SIDE EFFECT; THALASSEMIA; THROMBOCYTOPENIA;

EID: 30744471649     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.2005.17.6.651     Document Type: Article

References (18)

1. th ed. BC Decker Inc. 2004; 1156-1169.
2. Di Ciommo V, Russo P, Rava L, Caprino L. Interferon alpha in the treatment of chronic hepatitis C in children: a metanalysis. J Viral Hepat 2003; 10: 210-214.
3. Tabaru A, Narita R, Hiura M, Abe S, Otsuki M. Efficacy of short-term interferon therapy for patients infected with hepatitis C virus genotype 2a. Am J Gastroenterol 2005; 100: 862-867.
4. Snyder JD, Pickering LK. Viral hepatitis. In:Behrman ER, Kliegman MR, Jenson BH (eds). Nelson Textbook of Pediatrics, 17th ed. W.B. Saunders Co., Philadelphia, 2004; 1324-1332.
5. Jaeckel E, Cornberg M, Wedemeyer H, Santantonio T, Mayer J, Zankel M, et al. Acute Hepatitis C Therapy Group. Treatment of acute hepatitis C with interferon alfa-2b. N Engl J Med 2001; 345: 1452-1457.
6. Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, Wollman J, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981; 1: 431-435.
7. Russo MW, Goldsweig CD, Jacobson IM, Brown RS Jr. Interferon monotherapy for dialysis patients with chronic hepatitis C: an analysis of the literature on efficacy and safety. Am J Gastroenterol 2003; 98: 1610-1615.
8. Scotto G, Fazio V, Palumbo E, Cibelli DC, Saracino A, Angarano G. Treatment of genotype 1b HCV-related chronic hepatitis: efficacy and toxicity of three different interferon alfa-2b/ribavirin combined regimens in naive patients. New Microbiol 2005; 28: 23-29.
9. Potthoff A, Wiegand J, Luth JB, Wedemeyer H, Manns MP, Tillmann HL. Superiority of standard interferon-alpha2b compared to pegylated interferon-alpha2b (12 kDa) in a hemodialysis patient with chronic hepatitis C? Clin Nephrol 2005; 63: 232-235.
10. Napoli N, Giannelli G, Parisi CV, Antonaci A, Maddalena G, Antonaci S. Predictive value of early virological response to treatment with different interferon-based regimens plus ribavirin in patients with chronic hepatitis C. New Microbiol 2005; 28: 13-21.
11. Ebeling F, Lappalainen M, Vuoristo M, Nuutinen H, Leino R, Karvonen AL, et al. Factors predicting interferon treatment response in patients with chronic hepatitis C: late viral clearance does not preclude a sustained response. Am J Gastroenterol 2001; 96: 1237-1242.
12. Mamori S, Suzuki F, Hosaka T, Akuta N, Someya T, Kobayashi M, et al. Interferon monotherapy for patients with chronic hepatitis C and normal serum aminotransferase levels at commencement of treatment. J Gastroenterol 2004; 39: 776-782.
13. Russo MW, Brown RS Jr. Should patients with chronic hepatitis C who have normal ALT levels be treated? Curr Gastroenterol Rep 2001; 3: 49-53.
14. Jacobson IM, Ahmed F, Russo MW, Lebovics E, Dieterich DT, Esposito SP, et al. Interferon alpha-2b and ribavirin for patients with chronic hepatitis C and normal ALT. Am J Gastroenterol 2004; 99: 1700-1705.
15. Kamar N, Izopet J, Rostaing L. Hepatitis C infection among patients receiving hemodialysis. Nephrologie 2003; 24: 133-141.
16. Spiliopoulou I, Repanti M, Katinakis S, Karana-Ginopoulou A, Papanastasiou DA. Response to interferon alfa-2b therapy in multitransfused children with beta-thalassemia and chronic hepatitis C. Eur J Clin Microbiol Infect Dis 1999; 18: 709-715.
17. Di Marco V, Lo Iacono O, Almasio P, Ciaccio C, Capra M, Rizzo M, et al. Long-term efficacy of alpha- Interferon in beta-thalassemics with chronic hepatitis C. Blood 1997; 90: 2207-2212.
18. Li CK, Chan PK, Ling SC, Ha SY. Interferon and ribavirin as frontline treatment for chronic hepatitis C infection in thalassaemia major. Br J Haematol 2002; 117: 755-758.